MD, University of California, Los Angeles, CA, 1981
PhD, Biochemistry, University of Minnesota, Minneapolis, MN, 1993
Post Doctoral Education
Surgery Resident, University of Minnesota Health Sciences Center, Minneapolis, MN, 1989
Surgery, University of Minnesota Health Sciences Center, Minneapolis, MN, 1990
Surgical Critical Care Fellow,
Department of Surgery, University of Minnesota Health Sciences Center, Minneapolis, MN, 1991
Dr. Mazuski specializes in burn, trauma and surgical critical care. Other areas of clinical interest include surgical infections; nutrition support; pathophysiology of shock, sepsis, and multiple organ failure; and clinical guidelines for surgical infections and for critically ill patients.
Principal Investigator: "Intravenous telavancin versus vancomycin for treatment of complicated Gram-positive skin and skin structure infections, with a focus on patients with infections due to methicillin-resistant Staphylococcus aureus," Theravance, Inc., 2005-2006
Principal Investigator: "A randomized, double-blind, placebo-controlled study to assess the effect of recombinant human erythropoietin (epoetin alfa) on functional outcomes in anemic, critically il, trauma subjects," Ortho Biotech, LLC, 2006-2008
Local Investigator at Washington University School of Medicine: "SIS multicenter study of duration of antibiotocs for intra-abdominal infection," National Institutes of Health, 2008-2009
Principal Investigator: "Efficacy and safety of drotrecogin alfa (activated) in adult patients with septic shock," Eli Lilly and Co., 2008-2010
Principal Investigator: "A prospective, multi-center observational registry involving patients hospitalized with complicated skin and soft tissue infections (cSSTI) for IV antibiotic therapy," Ortho McNeil, 2008-2010
International Coordinating Investigator: "A phase III, randomized, multi-center, double-blind, double-dummy, comparative study to dertermine the efficacy, safety, and tolerability of ceftazidime avibactam (CAZ104) plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections (cIAIs) in hospitalized adults," Astra Zeneca, 2011-2014
Eaton SR, Mazuski JE. Overview of severe Clostridium difficile infection. Crit Care Clin. 2013 Oct.;29(4): 827-839.
Skrupky LP, Tellor BR, Mazuski JE. Current strategies for the treatment of complicated intraabdominal infections. Expert Opin Pharmacother. 2013;14:1933-1947.
Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, Freire AX, Geehan D, Kohl B, Nasraway SA, Rigby M, Sands K, Schallom L, Taylor B, Umpierrez G, Mazuski J, Schunemann H: Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012; 40:3251-3276.
Schwulst SJ, Mazuski JE: Surgical prophylaxis and complication avoidance care bundles. Surg Clin North America, 2012; 92:285-305.
Gnerlich JL, Ritter JH, Kirby JP, Mazuski JE: Simultaneous necrotizing soft tissue infection and colonic necrosis due to Clostridium septicum. Surg Infect. 2010; 12:501-506.
Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt). 2010 Feb;11(1):79-109.
Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010 Jan 15;50(2):133-64.
Byrnes MC, Schuerer DJ, Schallom ME, Sona CS, Mazuski JE, Taylor BE, McKenzie W, Thomas JM, Emerson JS, Nemeth JL, Bailey RA, Boyle WA, Buchman TG, Coopersmith CM. Implementation of a mandatory checklist of protocols and objectives improves compliance with a wide range of evidence-based intensive care unit practices. Crit Care Med. 2009 Oct;37(10):2775-81.
Efron PA, Mazuski JE. Clostridium difficile colitis. Surg Clin North Am. 2009 Apr;89(2):483-500, x.
Mazuski JE, Solomkin JS. Intra-abdominal infections. Surg Clin North Am. 2009 Apr;89(2):421-37, ix. Review.
Kirby JP, Mazuski JE. Prevention of surgical site infection. Surg Clin North Am. 2009 Apr;89(2):365-89, viii. Review.
Mazuski JE. Preface. Surg Clin North Am. 2009 Apr;89(2):xvii-xix.
Byrnes MC, Mazuski JE. Antimicrobial therapy for acute colonic diverticulitis. Surg Infect (Larchmt). 2009 Apr;10(2):143-54. Review.
Mazuski JE. Vancomycin-resistant enterococcus: risk factors, surveillance, infections, and treatment. Surg Infect (Larchmt). 2008 Dec;9(6):567-71.
Sona CS, Zack JE, Schallom ME, McSweeney M, McMullen K, Thomas J, Coopersmith CM, Boyle WA, Buchman TG, Mazuski JE, Schuerer DJ. The impact of a simple, low-cost oral care protocol on ventilator-associated pneumonia rates in a surgical intensive care unit. J Intensive Care Med. 2009 Jan-Feb;24(1):54-62.
Pub Med page for John E. Mazuski, MD, PhD
Mazuski JE, guest editor. Surgical Infections: Surgical Clinics of North America, 2009: Volume 89, Number 2.
2008-Present, Editorial Board, Surgical Infections
2001-Present, Intensive Care Medicine
2001-Present, Surgical Infections
2005-Present, Journal of the American College of Surgery
2007-Present, Expert Opinion on Investigational Drugs
2009-Present, American College of Critical Care
2009-Present, Lancet Infectious Diseases
2012-Present, Journal of Parenteral and Enteral Nutrition
Mazuski JE: Intra-abdominal infections. In: Fry D, ed. Surgical Infections. JP Medical Publishers, London, 2013; pp. 75-88.
Husain, KD, Mazuski JE, Hotchkiss, R: Life support and anesthesia. In: Klingensmith ME, Chen LE, Glasgow SC, Goers TA, Melby SJ, eds. The Washington Manual of Surgery, Washington University School of Medicine, 5th Edition, Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2008:46-70.
Taylor B, Mazuski J: Enteral access devices in the critically ill patient. In: Cresci G, ed. Nutrition Support for the Critically Ill Patient: A Guide to Practice. Boca Raton: Taylor and Francis Group; 2005:235-252.
Bailey JA, Mazuski JE: Divalent ions in the ICU. In: Abrams JH, Druck P, Cerra FB, eds. Surgical Critical Care, 2nd Edition. Boca Raton: Taylor and Francis Group; 2005:647-660.
Mazuski JE, Sawyer, R, Nathens A, DiPiro J, Schein M, Kudsk KA, Yowler C: Antibiotics as an adjunct to source control: Revised Surgical Infection Society guidelines for antimicrobial therapy of intra-abdominal infections. In: Marshall J, Schein M, eds. Source Control. Berlin Heidelberg: Springer-Verlag; 2003:427-441.